Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-010756

Chief Dev Operations Officer acquired 9,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Frenkel Ran · Chief Dev Operations Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-15 Exercise or conversion : show line 1 in the form +9,675 39,041 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2020-02-15 Exercise or conversion : show line 2 in the form Restricted Stock Units −9,675 9,675 29,025 D
Loading xslF345X03/doc4.xml…